Revenue decline of 22% YoY and a 38% drop in the core AlterG segment signal ongoing operational headwinds, partially offset by improved cash burn and a stronger balance sheet. The delayed 10-Q and the massive S-3 overhang (261% of shares outstanding) create uncertainty. Watch for the 10-Q filing and any updates on AlterG order fulfillment in Q2/Q3. The stock is a high-risk micro-cap with a going-concern warning from the prior auditor.
Price Chart
Executive Summary
Lifeward reported Q1 2026 revenue of $3.9M, down 22% YoY from $5.0M, and a GAAP net loss of $10.8M ($6.70/share) vs $4.8M ($5.53/share) a year ago. The headline miss is driven by a $4.9M non-cash acquired in-process R&D charge from the Oratech acquisition, but on an adjusted basis operating loss was flat at $4.6M. Cash burn improved 33% to $3.7M, and the balance sheet was strengthened to $11.4M cash after closing the Oramed strategic transaction and receiving $10M in financing. The 10-Q filing is delayed as the company finalizes accounting for the transaction.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $3.9M, down 22% YoY from $5.0M
- GAAP net loss $10.8M ($6.70/share) vs $4.8M ($5.53/share) YoY; includes $4.9M non-cash acquired in-process R&D charge
- Non-GAAP adjusted operating loss flat at $4.6M YoY
- Cash used in operations improved 33% to $3.7M from $5.5M YoY
- Cash balance increased to $11.4M from $2.2M at Dec 2025, driven by $10M financing and $6.5M cash acquired from Oratech
- ReWalk exoskeleton sales up 11% to $1.6M; AlterG revenue down 38% to $2.1M due to working capital constraints
- 10-Q filing delayed as company finalizes accounting for the strategic transaction
- S-3 filed 18 days ago registers 7.26M shares for resale (~261% of current shares outstanding) from selling shareholders
Financial Impact
Revenue miss of ~33% vs consensus ($3.9M actual vs $5.8M est); GAAP EPS miss of $6.70 vs $-0.34 consensus (driven by one-time charges)
Risk Factors
- Revenue declining 22% YoY with AlterG down 38% due to working capital constraints
- 10-Q filing delay introduces uncertainty and potential compliance risk
- Massive S-3 overhang of 261% of shares outstanding from selling shareholders
- Going-concern warning from prior auditor (substantial doubt)
- Gross margin compression from 42.2% to 34.2% YoY on lower production volumes and tariffs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001178913-26-002727 |
| Document: zk2635349.htm | 0001178913-26-002727 |
| Document: 0001178913-26-002727-index-headers.html | 0001178913-26-002727 |
| Document: 0001178913-26-002727-index.html | 0001178913-26-002727 |
| Document: 0001178913-26-002727.txt | 0001178913-26-002727 |
| 8-K Data (Synthetic) | 0001178913-26-002727 |
Track record
25 reports on LFWD
7 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
- Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
- Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
- Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
- Aug 14, 202613w ago 8-K Mixed 6/10 No price data
- Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
- Aug 11, 202614w ago EFFECT Bearish 7/10 Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers